Gene therapy of chronic granulomatous disease (CGD) by gene transfer into hematopoietic stem cells

Annali dell'Istituto Superiore di Sanita

Volumn 34, Issue 4, 1998, Pages 447-455

  Zentilin, Lorena ^a,b   Tafuro, Sabrina ^a,b   Serra, Cristina ^a,b   Falaschi, Arturo ^a   Giacca, Mauro ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

Author keywords

Chronic granulomatous disease (CGD); Gene therapy; Hematopoietic stem cells

Indexed keywords

CD34 ANTIGEN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ADENOVIRUS; ARTICLE; CHRONIC GRANULOMATOUS DISEASE; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HEMATOPOIETIC STEM CELL; HUMAN; RETROVIRUS;

ADENOVIRIDAE; ANTIGENS, CD34; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GRANULOMATOUS DISEASE, CHRONIC; HEMATOPOIETIC STEM CELLS; HUMANS; NADPH OXIDASE; RETROVIRIDAE; TRANSDUCTION, GENETIC;

EID: 0032234729     PISSN: 00212571     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. DINAUER, M.C., & ORKIN, S.H. 1992. Chronic granulomatous disease. Annu. Rev. Med. 43: 117-124
2. ORKIN, S.H. 1989. Molecular genetics of chronic granulomatous disease. Annu. Rev. Immunol. 7: 277-307.
3. McPHAIL, L.C. & SNYDERMAN, R. 1983. Activation of the respiratory burst enzyme in human polymorphonuclear leukocytes by chemoattractants and other soluble stimuli. Evidence that the same oxidase is activated by different transductional mechanisms. J. Clin. Invest. 72: 192-200.
4. BABIOR, B.M. 1984. The respiratory burst of phagocytes. J. Clin. Invest. 73: 599-601.
5. SMITH, R.M. & CURNUTTE, J.T. 1991. Molecular basis of chronic granulomatous disease. Blood 77: 673-680.
6. HEYWORTH, P.G. & BADWEY, J.A. 1990 Continuous phosphorylation of both the 47 and the 49 kDa proteins occurs during superoxide production by neutrophils. Biochim. Biophys. Acta 1052: 299-305.
7. ROTROSEN, D. & LETO, T.L. 1990. Phosphorylation of neutrophil 47-kDa cytosolic oxidase factor. Translocation to membrane is associated with distinct phosphorylation events. J. Biol. Chem. 265: 19910-19915.
8. DIEKMANN, D., ALBO, A., JOHNSTON, C., SEGAL, A.W. & HALL, A. 1994. Interaction of Rac with p67-phox and regulation of phagocytic NADPH oxidase activity. Science 265: 531-533.
9. CLARK, R.A., MALECH, H.L., GALLIN, J.I., NUNOI, H., VOLPP, B.D., PEARSON, D.W., NAUSEEF, W.M. & CURNUTTE, J.T. 1989. Genetic variants of chronic granulomatous disease: prevalence of deficiencies of two cytosolic components of the NADPH oxidase system. N. Engl. J. Med. 321: 647-652.
10. ROOS, D. 1994. The genetic basis of chronic granulomatous disease. Immunol. Rev. 138: 121-157.
11. ROOS, D., CURNUTTE, J.T., HOSSLE, H.-P., LAU, Y.L., ARIGA, T., NUNOI, H., DINAUER, M.C., GAHR, M., SEGAL, A.W., NEWBURGER, P.E., GIACCA, M., KEEP, N.H. & VAN ZWIETEN, R. 1996. X-CGDbase: a database of X-CGD-causing mutations. Immunology Today 17: 517-521.
12. ROOS, D., DE BOER, M., KURIBAYASHI, F., MEISCHL, C., WEENING, R.S., SEGAI, A.W., AHLIN, A., NEMET, K., HOSSLE, J.P., BERNATOWSKA-MATUSZKIEWICZ, E. & MIDDLETONPRICE, H. 1996. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood 87: 1663-1681.
13. MOUY, R., SEGER, R., BOURQUIN, J.P., VEBER, F., BLANCHE, S., GRISCELLI, C. & FISCHER, A. 1991. Interferon-gamma for chronic granulomatous disease. N. Engl. J. Med. 325: 1516.
14. HOBBS, J.R., MONTEIL, M., MCCLUSKEY, D.R., JURGES, E. & ELTUMI, M. 1992. Chronic granulomatous disease 100% corrected by displacement bone marrow transplantation from a volunteer unrelated donor. Eur. J. Pediatr. 151: 806-810.
15. WOODMAN, R.C., NEWBURGER, P.E., ANKLESARIA, P., ERICKSON, R.W., RAE, J., COHEN, M.S. & CURNUTTE, J.T. 1995. A new X-linked variant of chronic granulomatous disease characterized by the existence of a normal clone of respiratory burst-competent phagocytic cells. Blood 85: 231-241.
16. MALY, F.E., NAKAMURA, M., GAUCHAT, A., URWYLER, C., WALKER, C., DAHINDEN, C.A., CROSS, A.R., JONES, O.T. & DE WECK, A.L. 1989. Superoxide dependent nitrobluetetrazolium reduction and expression of cytochrome b245 components by human B-lymphocytes and B-cell lines. J. Immunol. 142: 1260-1267.
17. HANCOCK, J.T., HENDERSON, L.M. & JONES, O.T.G. 1990. Superoxide generation by EBVtransformed B lymphocytes. Activation by IL-1β, TNF-α, and receptor indipendent stimuli. Immunology 71: 213-217.
18. LECA, G., BENICHOU, G., BENSUSSAN, A., MITENNE, F., GALANAUD, P. & VAZQUEZ, A. 1991. Respiratory burst in human B lymphocytes: triggering of surface Ig receptors induces modulation of chemiluminescence signal. J. Immunol. 146: 3542-3549.
19. VOLKMAN, D.J., BUESCHER, E.S., GALLIN, J.I. & FAUCI, A.S. 1984. B cell lines as models for inherited phagocytic diseases: abnormal superoxide generation in chronic granulomatous disease and giant granules in Chediak-Higashi syndrome. J. Immunol. 133: 3006-3009.
20. MORGENSTERN, J.P. & LAND, H. 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18: 3587-3596.
21. ZENTILIN, L., TAFURO, S., GRASSI, G., GARCIA, R., VENTURA, A., BARALLE, F.E., FALASCHI, A. & GIACCA, M. 1996. Functional reconstitution of oxidase activity in X-linked chronic granulomatous disease by retrovirus-mediated gene transfer. Exp. Cell. Res. 225: 257-267.
22. KUME, A. & DINAUER, M.C. 1994. Retrovirus-mediated reconstitution of respiratory burst activity in X-linked chronic granulomatous disease cells. Blood 84: 3311-3316.
23. SEKHSARIA, S., GAILIN, J.I., LINTON, G.F., MALLORY, R.M., MULLIGAN, R.C. & MALECH, H.L. 1993. Peripheral blood progenitors as a target for genetic correction of p47phox-deficient chronic granulomatous disease. Proc. Natl. Acad. Sci. USA 90: 7446-7450.
24. + peripheral blood progenitors as a target for genetic correction of the two flavocytochrome b558 defective forms of chronic granulomatous disease. Blood 84: 53-58.
25. PORTER, C.D., PARKAR, M.H., COLLINS, M.K., LEVINSKY, R.J. & KINNON, C. 1996. Efficient retroviral transduction of human bone marrow progenitor and long-term culture-initiating cells: partial reconstitution of cells from patients with X-linked chronic granulomatous disease by gp91-phox expression. Blood 87: 722-3730.
26. DING, C., KUME, A., BJORGVINSDOTTIR, H., HAWLEY, R.G., PECH, N. & DINAUER, M.C. 1996. High-level reconstitution of respiratory burst activity in a human X-linked chronic granulomatous disease (X-CGD) cell line and correction of murine X-CGD bone marrow cells by retroviral-mediated gene transfer of human gp91-phox. Blood 88: 1834-1840.
27. MILLER, D.G., ADAM, M.A. & MILLER, A.D. 1990. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10: 4239-4242.
28. GALLAY, P., SWINGLER, S., SONG, J., BUSHMAN, F. & TRONO, D. 1995. HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell 83: 569-576.
29. + bone marrow cells. Blood 82: 1975-1980.
30. DUNBAR, C.E., COTTLER-FOX, M., O'SHAUGHNESSY, J.A., DOREN, S., CARTER, C., BERENSON, R., BROWN, S., MOEN, R.C., GREENBLATT, J., STEWART, F.M., LEITMAN, S.F., WILSON, W.H., COWAN, K., YOUNG, N.S. & NIENHIUS, A.W. 1995. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 85: 3048-3057.
31. KOHN, D.B. 1995. The current status of gene therapy using hematopoietic stem cells. Curr. Opin. Pediatr. 7: 56-63.
32. BARRANGER, J.A. 1996. Haematopoietic stem cell gene transfer. Gene Ther. 3: 379-380.
33. LAROCHELLE, A., VORMOOR, J., HANENBERG, H., WANG, J.C.Y., BHATIA, M., TSVEE, L., MORITZ, T., MUDROCH, B., XIAO, X.L., KATO, I., WILLIAMS, D.A. & DICK, J.E. 1996. Identification of primitive human hematopoietic cells capable of repopulating NOD/SICD mouse bone marrow: implications for gene therapy. Nature Med. 2: 1329-1336.
34. MUZYCZKA, N. 1992. Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr. Top. Microbiol. Immunol. 158: 97-129.
35. BULLER, R.M., STRAUS, S.E. & ROSE, J.A. 1979. Mechanism of host restriction of adenovirus-associated virus replication in African green monkey kidney cells. J. Gen. Virol. 43: 663-672.
36. BERNS, K.I. & LINDEN, R.M. 1995. The cryptic life style of adeno-associated virus. Bioessays 17: 237-245.
37. FLOTTE, T.R. & CARTER, B.J. 1995. Adeno-associated virus vectors for gene therapy. Gene Ther. 2: 357-362.
38. ZHOU, S.Z., COOPER, S., KANG, L.Y., RUGGIERI, L., HEIMFELD, S. & SRIVASTAVA, A. 1994. Adeno-associated virus 2-mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood. J. Exp. Med. 179: 1867-1875.
39. MILLER, J.L., DONAHUE, R.E., SELLERS, S.E., SAMULSKI, R.J., YOUNG, N.S. & NIENHUIS, A.W. 1994. Recombinant adeno-associated virus (rAAV)-mediated expression of a human gamma-globin gene in human progenitor-derived erythroid cells. Proc. Natl. Acad. Sci. USA 91: 10183-10187.
40. + human hematopoietic progenitor cells after transduction. Blood 88: 492-504.
41. KOTIN, R.M., SINISCALCO, M., SAMULSKI, R.J., ZHU, X.D., HUNTER, L., LAUGHLIN, C.A., McLAUGHLIN, S., MUZYCZKA, N., ROCCHI, M. & BERNS, K.I. 1990. Site-specific integration by adeno-associated virus. Proc. Natl. Acad. Sci. USA 87: 2211-2215.
42. KOTIN, R.M., LINDEN, R.M. & BERNS, K.I. 1992. Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO J. 11: 5071-5078.
43. SAMULSKI, R.J., CHANG, L.S. & SHENK, T. 1989. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J. Virol. 63: 3822-3828.
44. TAFURO, S., ZENTILIN, L., FALASCHI, A. & GIACCA, M. 1996. Rapid retrovirus titration using competitive polymerase chain reaction. Gene Ther. 3: 679-684.
45. DIVIACCO, S., NORIO, P., ZENTILIN, L., MENZO, S., CLEMENTI, M., FALASCHI, A. & GIACCA, M. 1992. A novel procedure for quantitative polymerase chain reaction by coamplification of competitive templates. Gene 122: 3013-3020.
46. NOLTA, J.A. & KOHN, D.B. 1990. Comparison of the effects of growth factors on retroviral vector-mediated gene transfer and the proliferative status of human hematopoietic progenitor cells. Hum. Gene Ther. 1: 257-268.
47. METCALF, D. & NICOLA, N.A. 1991. Direct proliferative actions of stem cell factor on murine bone marrow cells in vitro: effects of combination with colony-stimulating factors. Proc. Natl. Acad. Sci. USA 88: 6239-6243.
48. XU, L.C., YOUNG, H.A., BLANCO, M., KESSLER, S., ROBERTS, A.B. & KARLSSON, S. 1994. Poor transduction efficiency of human hematopoietic progenitor cells by a high-liter amphotropic retrovirus producer cell clone. J. Virol. 68: 7634-7636.
49. NOLTA, J.A., SMOGORZEWSKA, E.M. & KOHN, D.B. 1995. Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells. Blood 86: 101-110.
50. NOLTA, J.A., DAO, M.A., WELLS, S., SMOGORZEWSKA, E.M. & KOHN, D.B. 1996. Transduction of pluripotent human hematopoietic stem cells demonstrated by clonal analysis after engraftment in immune-deficient mice. Proc. Natl. Acad. Sci. USA 93: 2414-2419.
51. SALOMON, O., LAPIDOT, T., TERENZI, A., LUBIN, I., RABI, I. & REISNER, Y. 1990. Induction of donor-type chimerism in murine recipients of bone marrow allografts by different radiation regimens currently used in treatment of leukemia patients. Blood 76: 1872-1878.
52. VORMOOR, J., LAPIDOT, T., PFLUMIO, F., RISDON, G., PATTERSON, B., BROXMEYER, H.E. & DICK, J.E. 1994. Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodeficient mice. Blood 83: 2489-2497.
53. SHULTZ, L.D., SCHWEITZER, P.A., CHRISTIANSON, S.W., GOTT, B., SCHWEITZER, I.B.,TENNENT, B., Mc KENNA, S., MOBRAATEN, L., RAJAN, T.V., GREINER, D.L. et al. 1995. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-seid mice. J. Immunol. 154: 180-191.
54. BATHIA, M., WANG, J.C.Y., KAPP, U., BONNET, D. & DICK, J.E. 1997. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc. Natl. Acad. Sci. USA 94: 5320-5325.
55. WANG, J.C., DOEDENS, M. & DICK, J.E. 1997. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood 89: 3919-3924.
56. BATHIA, M., BONNET, D., MURDOCH, B., GAN, O.I. & DICK, J.E. 1998. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nature Med. 4: 1038-1045.
57. GOODELL, M.A., ROZENZWEIG, M., KIM, H., MARKS, D.F., DEMARIA, M.A., PARADIS, G., GRUPP, S.A., SIEFF, C.A., MULLIGAN, R.C. & JOHNSON, R.P. 1997. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nature Med. 3: 1337-1345.
58. SORRENTINO, B.P., Mc DONAGH, K.T., WOODS, D. & ORLIC, D. 1995. Expression of retroviral vectors containing the human multidrug resistance 1 cDNA in hematopoietic cells of transplanted mice. Blood. 86: 491-501.
59. LI, M.-X., BANERJEE, D., ZHAO, S.-C., SCHWEIRER, B.I., MINEISHI, S., GILBOA, E. & BERTINO, J. 1994. Development of a retroviral construct containing a human mutated dihydrofolate reductase cDNA for hematopoietic stem cell transduction. Blood 83: 3403-3408.
60. ALLAY, J.A., PERKSON, D.A., GALIPEAU, J., RIBERDY, J.M., ASHMUN, R.A., BLAKLEY, R.L. & SORRENTINO, B.P. 1998. In vivo selection of retrovirally transduced hematopoietic stem cells. Nature Med. 4: 1136-1143.
61. BERNS, K.I. 1990. Parvovirus replication. Microbiol. Rev. 54: 316-329.
62. ALEXANDER, I.E., RUSSELL, D.W., SPENCE, A.M. & MILLER, A.D. 1996. Effects of gamma irradiation on the transduction of dividing and nondividing cells in brain and muscle of rats by adeno-associated virus vectors. Hum. Gene Ther. 7: 841-850.
63. LINDEN, R.M., WARD, P., GIRAUD, C., WINOCOUR, E. & BERNS, K.I. 1996. Site-specific integration by adeno-associated virus. Proc. Natl. Acad. Sci. USA 93: 11288-11294.
64. CLARK, K.R., VOULGAROPOULOU, F., FRALEY, D.M. & JOHNSON, P.R. 1995. Cell lines for the production of recombinant adeno-associated virus. Hum. Gene Ther. 6: 1329-1341.
65. TARNAYOSE, K., HIRAI, Y. & SHIMADA, T. 1996. A new strategy for large-scale preparation of high-titer recombinant adeno-associated virus vectors by using packaging cell lines and sulfonated cellulose column chromatography. Hum. Gene Ther. 7: 507-13.
66. NALDINI, L., BLOMER, U., GALLAY, P., ORY, D., MULLIGAN, R., GAGE, F.H., VERMA, I.M. & TRONO, D. 1996. In vivo gene delivery and stable transduction of non-dividing cells by a lentiviral vector. Science 272: 263-267.
67. POESCHLA, E., CORBEAU, P. & FLOSSIE, W.-S. 1996. Development of HIV vectors for anti-HIV gene therapy. Proc. Natl. Acad. Sci. USA 93: 11395-11399.
68. HEINZINGER, N.K., BUKINSKY, M.I., HAGGERTY, S.A., RAGLAND, A.M., KEWALRAMANI, V., LEE, M.A., GENDELMAN, H.E., RATNER, L., STEVENSON, M. & EMERMAN, M. 1994. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in non dividing host cells. Proc. Natl. Acad. Sci. USA 91: 7311-7373.